Company intelligence / Profile preview

Novaprint Therapeutics

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Novaprint Therapeutics is developing regenerative medical implant devices using advanced 3D printing technologies. The company has filed at least one patent related to applications in oral/maxillofacial surgery, dentistry, otorhinolaryngology, and orthopedics. There are no reported clinical results or commercialized products as of June 2025.

Therapeutic areas: Other
Modalities: Medical implant devices3D printed medical devices for oral/maxillofacial surgery and dentistry
Industry: Implantable Medical Devices

Partnerships

MedTech Innovator Asia Pacific incubator/accelerator program investor/supporter

Beyond the preview

Go deeper on Novaprint Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novaprint Therapeutics.

Explore the full profile